SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________
SCHEDULE 13D/A
(RULE 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13D-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13D-2(a)
(AMENDMENT NO. 2)
_______________________
LIFE TECHNOLOGIES, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $.01 PER SHARE
(Title of Class of Securities)
532177201
(CUSIP Number)
BRUCE H. BEATT, ESQ.
VICE PRESIDENT, GENERAL COUNSEL AND SECRETARY
DEXTER CORPORATION
ONE ELM STREET
WINDSOR LOCKS, CT
(860) 292-7675
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
_______________________
COPY TO:
J. MICHAEL SCHELL, ESQ.
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
FOUR TIMES SQUARE
NEW YORK, NEW YORK 10036-6522
(212) 735-3000
JANUARY 28, 2000
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check
the following box: [ ]
CUSIP No. 532177201
--------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS: Dexter Corporation
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
06-0321410
--------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ____
(b) ____
--------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------
4. SOURCE OF FUNDS (See Instructions):
BK
--------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e)
_____
--------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Connecticut
--------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON WITH
--------------------------------------------------------------------------
7. SOLE VOTING POWER 13,132,960 shares
--------------------------------------------------------------------------
8. SHARED VOTING POWER 5,569,187 shares
--------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER 0 shares
--------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER 18,702,147 shares
--------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
18,702,147 shares
--------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
_________
--------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
74.8 %
--------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------
CUSIP No. 532177201
--------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS: Dexter Acquisition Delaware, Inc.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
51-0386042
--------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ____
(b) ____
--------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------
4. SOURCE OF FUNDS (See Instructions):
AF
--------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e)
_____
--------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON WITH
--------------------------------------------------------------------------
7. SOLE VOTING POWER 0 shares
--------------------------------------------------------------------------
8. SHARED VOTING POWER 5,569,187 shares
--------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER 0 shares
--------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER 5,569,187 shares
--------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,569,187 shares
--------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
__________
--------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.3 %
--------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------
Dexter Corporation, a Connecticut corporation ("Parent"), and
Dexter Acquisition Delaware, Inc., a Delaware corporation and a wholly
owned subsidiary of Parent ("Purchaser"), hereby amend and supplement the
report on Schedule 13D, originally filed on December 23, 1998, as amended
by the Schedule 13D/A No. 1, dated January 24, 2000 (as amended, the
"Schedule 13D"), with respect to their ownership of shares of Common Stock,
par value $.01 per share, of Life Technologies, Inc., a Delaware
corporation (the "Company"). Capitalized terms used herein but not
otherwise defined shall have the meanings assigned to them in the Schedule
13D.
The Schedule 13D is hereby amended and supplemented as follows:
ITEM 3. SOURCE AND AMOUNT OF FUNDS AND OTHER CONSIDERATIONS.
The purchase by Parent of 825,245 shares on January 28, 2000 was
financed through uncommitted credit lines.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
The response to Item 5 is hereby amended and supplemented as
follows:
"On January 28, 2000, Parent purchased 825,245 Shares in a
privately negotiated transaction for an aggregate purchase price of
$40,437,005 or a per Share purchase price of $49.00."
SIGNATURES
After reasonable inquiry and to the best knowledge and belief of
the entity set forth below, such entity certifies that the information set
forth in this Statement is true, complete, and correct.
January 28, 2000
DEXTER CORPORATION
By: /s/ Bruce H. Beatt
---------------------------------
Bruce H. Beatt
Vice President, General Counsel
and Secretary
DEXTER ACQUISITION DELAWARE, INC.
By: /s/ Kathleen Burdett
---------------------------------
Kathleen Burdett
Treasurer
